ClinConnect ClinConnect Logo
Search / Trial NCT06469125

Anatomic Endoscopic Prostate Enucleation and BICEP Classification

Launched by NECMETTIN ERBAKAN UNIVERSITY · Jun 14, 2024

Trial Information

Current as of July 01, 2025

Enrolling by invitation

Keywords

Bicep Classification Anatomic Endoscopic Enucleation Of Prostate Bladder Injury Ho Lep Bi Lep Thu Flep

ClinConnect Summary

Insufficient knowledge exists about bladder injuries during morcellation, as the existing literature primarily consists of isolated case reports. The Bladder Injury Classification System for Endoscopic Procedures (BICEP) aims to standardize the reporting and management of bladder injuries during endoscopic surgeries.

This study proposes an external validation of the BICEP system through an international, multicenter, prospective observational study. The objectives of this study are fourfold:

Validate the newly developed BICEP classification system with real-life clinical scenarios to ensu...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged ≥40
  • ASA (American Society of Anesthesiologists) score ≤3
  • Estimated weight on ultrasound (USG) ≥40 grams for prostate weight
  • Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery.
  • Exclusion Criteria:
  • Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease.
  • Patients with active urinary tract infection.
  • Patients diagnosed with bladder cancer within the last 2 years.
  • Patients with prostate cancer.
  • Patients who have undergone previous prostate surgery.

About Necmettin Erbakan University

Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.

Locations

Istanbul, , Turkey

Konya, , Turkey

Patients applied

0 patients applied

Trial Officials

Selçuk Güven, Prof. Dr.

Study Director

Necmettin Erbakan University

Bülent Erkurt, Prof. Dr.

Study Chair

Istanbul Medipol University Hospital

Selim Soytürk, RA

Principal Investigator

Necmettin Erbakan University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported